These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29325280)

  • 1. [Clinical value of anti-liver/kidney microsomal-1 antibody in patients with liver disease].
    Han Y; Yan HP; Liao HY; Sun LM; Huang YL; Huang CY; Zhang HP; Zhang XD; Bian XQ; Ren MX; Du XF; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):852-857. PubMed ID: 29325280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].
    Zhang HP; Yan HP; Lou JL; Huang CY; Ma YX; Li LJ; Han Y; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1182-1187. PubMed ID: 35045634
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody Profile of Adult Patients With Childhood Onset Type 2 Autoimmune Hepatitis.
    Woynarowski M; Woźniak M; Cukrowska B; Wierzbicka A; Lytton SD
    J Clin Lab Anal; 2016 Sep; 30(5):590-6. PubMed ID: 26676069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.
    Monti V; Aghemo A; Rumi MG; Donato MF; Del Ninno E; Colombo M
    Antivir Ther; 2005; 10(6):715-20. PubMed ID: 16218170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
    Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
    J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
    Zachou K; Rigopoulou E; Dalekos GN
    J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
    Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
    J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.
    Amin K; Rasool AH; Hattem A; Al-Karboly TA; Taher TE; Bystrom J
    World J Gastroenterol; 2017 Feb; 23(8):1345-1352. PubMed ID: 28293081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of autoimmune hepatitis in 11 children].
    Lu Y; Wang XH; Wang JS
    Zhonghua Er Ke Za Zhi; 2010 Oct; 48(10):758-63. PubMed ID: 21176485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
    Dalekos GN; Zachou K; Liaskos C; Gatselis N
    Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure of autoimmune aetiology in children.
    Di Giorgio A; Bravi M; Bonanomi E; Alessio G; Sonzogni A; Zen Y; Colledan M; D'Antiga L
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):159-64. PubMed ID: 25304891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hepatitis in childhood: a 20-year experience.
    Gregorio GV; Portmann B; Reid F; Donaldson PT; Doherty DG; McCartney M; Mowat AP; Vergani D; Mieli-Vergani G
    Hepatology; 1997 Mar; 25(3):541-7. PubMed ID: 9049195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club.
    Lindgren S; Braun HB; Michel G; Nemeth A; Nilsson S; Thome-Kromer B; Eriksson S
    Scand J Gastroenterol; 1997 Feb; 32(2):175-8. PubMed ID: 9051879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.